Stock Taper
SCREENER COMPARE ANY 2 STOCKS
IMNN
IMUNON, INC.
NASDAQ
$1.60
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$6.72 M
52w High$6.04
52w Low$1.47
Dividend Yield—
Frequency—
P/E-0.31
Volume82.34K
Shares Out.4.20M

COMPANY

LEADERSHIP

Stacy R. Lindborg
CHIEF EXECUTIVE
Stacy R. Lindborg

COMPENSATION 2026

Salary$568,139
Stock Awards$0
Incentive Plan Pay$357,210
All Other Comp.$0
Total$1,029,349

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 1, 1999
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
20

PRICE TARGET

Target High$10.00
Target Low$10.00
Target Median$10.00
Target Consensus$10.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.—
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2025-07-25Reverse1:15
2022-03-01Reverse1:15
2017-05-30Reverse1:14
2013-10-29Reverse111:500
2006-02-28Reverse1:15

PRICE

$1.60 ▲ UP 0.00% (+$0.00)
OVERLAYS
$1.58$1.60$1.62$1.649:44 AM10:47 AM11:49 AM12:52 PM1:54 PM2:57 PM3:59 PM1.60

About Imunon, Inc.

https://www.imunon.com ↗

Imunon, Inc. is a biotech company developing DNA-based immunotherapies, vaccines, and chemotherapies, including GEN-1 for ovarian cancer and ThermoDox, with platform technologies for nucleic acid-based cancer treatments.

INDUSTRY

Biotechnology

A PRODUCT IMUNON, INC. IS KNOWN FOR

IMNN-001
IMNN-001

IMNN-001, Imunon's lead DNA-based immunotherapy using TheraPlas® to deliver IL-12, is in Phase 3 trials for localized treatment of advanced ovarian cancer.

COMPETITORS

COMPETITOR
GNPX COMPARE
INO COMPARE
ONCY COMPARE
PGEN COMPARE
TCRT COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 47.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
11.88%
HOLDERS
16
TOP 12 OF 16 · RANKED BY POSITION SIZE
Armistice Capital, LLC
348.3K sh · $1.02M
Blackrock Inc.
58.2K sh · $67.54K
Riverview Capital Advisers, LLC
34.4K sh · $247.76K
Geode Capital Management, LLC
33.2K sh · $97.64K
Hrt Financial LP
12.1K sh · $35K
Blackrock, Inc.
4.5K sh · $13.12K
Wells Fargo & Company/Mn
3.3K sh · $9.83K
Morgan Stanley
3.0K sh · $8.92K
Tower Research Capital LLC (Trc)
1.9K sh · $5.49K
M&R Capital Management Inc
333 sh · $353
Group One Trading, L.P.
6 sh · $18
Federation Des Caisses Desjardins Du Quebec
5 sh · $15

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: EXECUTIVE CHAIRMAN OF BOARD
Tardugno Michael H
Purchase · 7.1K shares
2026-08-14
★
OFFICER: CHIEF MEDICAL OFFICER
Faller Douglas Vincent
Purchase · 3.5K shares
2026-08-14
★
OFFICER: GENERAL COUNSEL AND CORP SEC
Eylward Susan
Purchase · 2.4K shares
2026-08-14
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Lindborg Stacy
Purchase · 6.6K shares
2026-08-14

SECTORS PEERS

PEERPRICE
DWTX$2.65COMPARE
CING$5.33COMPARE
MRKR$1.37COMPARE
CLRB$2.53COMPARE
COCP$1.10COMPARE
AEON$0.31COMPARE
TRAW$0.59COMPARE
BOLT$3.81COMPARE